Stock Research for EVOK

EVOK

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

EVOK Stock Chart & Research Data

The EVOK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the EVOK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


EVOK Due diligence Resources & Stock Charts

The EVOK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View EVOK Detailed Price Forecast - CNN Money CNN View EVOK Detailed Summary - Google Finance
Yahoo View EVOK Detailed Summary - Yahoo! Finance Zacks View EVOK Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View EVOK Trends & Analysis - Trade-Ideas Barrons View EVOK Major Holders - Barrons
NASDAQ View EVOK Call Transcripts - NASDAQ Seeking View EVOK Breaking News & Analysis - Seeking Alpha
Spotlight View EVOK Annual Report - CompanySpotlight.com OTC Report View EVOK OTC Short Report - OTCShortReport.com
TradeKing View EVOK Fundamentals - TradeKing Charts View EVOK SEC Filings - Bar Chart
WSJ View Historical Prices for EVOK - The WSJ Morningstar View Performance/Total Return for EVOK - Morningstar
MarketWatch View the Analyst Estimates for EVOK - MarketWatch CNBC View the Earnings History for EVOK - CNBC
StockMarketWatch View the EVOK Earnings - StockMarketWatch MacroAxis View EVOK Buy or Sell Recommendations - MacroAxis
Bullish View the EVOK Bullish Patterns - American Bulls Short Pains View EVOK Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View EVOK Stock Mentions - StockTwits PennyStocks View EVOK Stock Mentions - PennyStockTweets
Twitter View EVOK Stock Mentions - Twitter Invest Hub View EVOK Investment Forum News - Investor Hub
Yahoo View EVOK Stock Mentions - Yahoo! Message Board Seeking Alpha View EVOK Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for EVOK - SECform4.com Insider Cow View Insider Transactions for EVOK - Insider Cow
CNBC View EVOK Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for EVOK - OTC Markets
Yahoo View Insider Transactions for EVOK - Yahoo! Finance NASDAQ View Institutional Holdings for EVOK - NASDAQ


Stock Charts

FinViz View EVOK Stock Insight & Charts - FinViz.com StockCharts View EVOK Investment Charts - StockCharts.com
BarChart View EVOK Stock Overview & Charts - BarChart Trading View View EVOK User Generated Charts - Trading View




Latest Financial News for EVOK


At $2.8701, Is Evoke Pharma Inc (NASDAQ:EVOK) A Buy?
Posted on Wednesday June 06, 2018

Evoke Pharma Inc (NASDAQ:EVOK), a pharmaceuticals company based in United States, received a lot of attention from a substantial price increase on the NasdaqCM over the last few months. WithRead More...


Evoke Announces FDA Submission of New Drug Application for Gimoti™
Posted on Monday June 04, 2018

Evoke Pharma, Inc. (EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced the submission of its 505(b)(2) New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Gimoti™, the Company’s nasal spray product candidate for the relief of symptoms in adult women with acute and recurrent diabetic gastroparesis. “Our NDA submission for Gimoti represents a significant step forward for Evoke and Gimoti, which has the potential to meaningfully improve the lives of patients who suffer from the devastating symptoms of gastroparesis,” commented Dave Gonyer, President and CEO. Existing oral treatment options may be ineffective during an acute flare, which we believe creates the need for a nonoral treatment option.


Evoke Pharma Inc (NASDAQ:EVOK) Is Expected To Breakeven
Posted on Monday May 14, 2018

Evoke Pharma Inc’s (NASDAQ:EVOK): Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. On 31 December 2017,Read More...


Evoke Pharma Reports First Quarter 2018 Results and Highlights
Posted on Monday May 14, 2018

NDA submission for Gimoti™ on track for second quarter of 2018 Announced discovery of sex-based pharmacokinetic differences for Gimoti Waiver of the PDUFA fee for Gimoti NDA granted by FDA Cash runway ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.